GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach diabetes mellitus . These injectable therapies work by mimicking the body’s own GLP-1 https://elodieceuc657639.blogdomago.com/40413681/glp-1-a-revolutionary-advance-in-diabetes-management